Peripheral T-cell lymphoma. A clinicopathologic study of a morphologically diverse entity

Area of Science:

• Hematology
• Oncology
• Pathology

Background:

• Peripheral T-cell lymphomas (PTCLs) are aggressive non-Hodgkin lymphomas with diverse clinical behaviors.
• Accurate classification is crucial for predicting patient outcomes and guiding treatment strategies.

Purpose of the Study:

• To analyze the clinicopathologic features of PTCL subtypes.
• To evaluate the response to chemotherapy and survival rates across different PTCL classifications.

Main Methods:

• Retrospective analysis of 13 patients with immunologically confirmed PTCL.
• Classification based on morphologic subtypes: poorly differentiated lymphocytic, mixed cell, and large cell.
• Assessment of treatment response and survival data for patients receiving multiagent chemotherapy.

Main Results:

• Poorly differentiated or mixed cell PTCLs showed limited complete remission rates (3/9) and a median survival of 11 months.
• Large cell PTCLs demonstrated a complete remission rate of 100% (3/3) in treated patients.
• Two patients with large cell PTCL remained disease-free at 14 and 29 months post-treatment.

Conclusions:

• Morphologic classification, including subtyping of heterogeneous groups, is essential for identifying prognostic factors in PTCL.
• Large cell PTCL appears to have a more favorable response to chemotherapy compared to other subtypes.
• Further research into PTCL subclassification can refine treatment approaches and improve patient outcomes.